Table 6.
Phase | Primary outcome | Steps | Factors | Pathway designation |
---|---|---|---|---|
Pre-submission | Define evaluation pathway | Pre-submission to PCC | Pre-submission coordination committee | Pathway designation |
New intervention pathway | Validated public health value of product class | Concept review and data definition | VCAG | Defined data required to validate public health value and support a WHO policy recommendation |
Development of assessment standards | VCAG product developer | Developed efficacy test guidelines, SOPs, quality and safety standards, and criteria | ||
Manufacturer-led data generation | VCAG product developer | Clinical trial results | ||
PQT inspection | PQT product developer | Report from manufacturing facility inspection | ||
Data assessment and recommendation to MPAC | VCAG | Final VCAG report to MPAC | ||
Good Manufacturing Practices/Neglected Tropical Disease/PQT Assessment | 1) Policy recommendation issued 2) Product prequalified | MPAC/STAG assessment | MPAC | MPAC meeting report |
PQT assessment | PQT | Product listing | ||
Post-recommendation activities | Programmatic use | Country health authority review | MoHs NMCP | Country policy issued |
Country regulatory review | MoHs Reg. authorities | Product registered in country | ||
Country procurement | MoHs GFTAM/UN/PMI | Product procured by countries | ||
Country use | MoH NMCP | Roll out and monitoring | ||
Post-PQT activities | Ongoing inspections and assessments | Post-PQT activities | PQT |
MPAC = Malaria Policy Advisory Committee; PCC = preferred product characteristics; PQT = prequalification team; VCAG = Vector Control Advisory Group.